Research ExplorerPublicationsEarly onset of treatment effects with oral risperidone.

Early onset of treatment effects with oral risperidone.

Standard

Early onset of treatment effects with oral risperidone. / Raedler, Thomas J; Schreiner, Andreas; Naber, Dieter; Wiedemann, Klaus.

In: BMC PSYCHIATRY, Vol. 7, 2007, p. 4.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Raedler, TJ, Schreiner, A, Naber, D & Wiedemann, K 2007, 'Early onset of treatment effects with oral risperidone.', BMC PSYCHIATRY, vol. 7, pp. 4. https://doi.org/10.1186/1471-244X-7-4

APA

Raedler, T. J., Schreiner, A., Naber, D., & Wiedemann, K. (2007). Early onset of treatment effects with oral risperidone. BMC PSYCHIATRY, 7, 4. https://doi.org/10.1186/1471-244X-7-4

Vancouver

Raedler TJ, Schreiner A, Naber D, Wiedemann K. Early onset of treatment effects with oral risperidone. BMC PSYCHIATRY. 2007;7:4. https://doi.org/10.1186/1471-244X-7-4

Bibtex

@article{e0c1fbbecc0840e1aac70c1c2cb19d5e,
title = "Early onset of treatment effects with oral risperidone.",
abstract = "BACKGROUND: The dogma of a delayed onset of antipsychotic treatment effects has been maintained over the past decades. However, recent studies have challenged this concept. We therefore performed an analysis of the onset of antipsychotic treatment effects in a sample of acutely decompensated patients with schizophrenia. METHODS: In this observational study, 48 inpatients with acutely decompensated schizophrenia were offered antipsychotic treatment with oral risperidone. PANSS-ratings were obtained on day 0, day 1, day 3, day 7 and day 14. RESULTS: Significant effects of treatment were already present on day 1 and continued throughout the study. The PANSS positive subscore and the PANSS total score improved significantly more than the PANSS negative subscore. CONCLUSION: Our results are consistent with the growing number of studies suggesting an early onset of antipsychotic treatment effects. However, non-pharmacological effects of treatment also need to be taken into consideration.",
author = "Raedler, {Thomas J} and Andreas Schreiner and Dieter Naber and Klaus Wiedemann",
year = "2007",
doi = "10.1186/1471-244X-7-4",
language = "Deutsch",
volume = "7",
pages = "4",
journal = "BMC PSYCHIATRY",
issn = "1471-244X",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Early onset of treatment effects with oral risperidone.

AU - Raedler, Thomas J

AU - Schreiner, Andreas

AU - Naber, Dieter

AU - Wiedemann, Klaus

PY - 2007

Y1 - 2007

N2 - BACKGROUND: The dogma of a delayed onset of antipsychotic treatment effects has been maintained over the past decades. However, recent studies have challenged this concept. We therefore performed an analysis of the onset of antipsychotic treatment effects in a sample of acutely decompensated patients with schizophrenia. METHODS: In this observational study, 48 inpatients with acutely decompensated schizophrenia were offered antipsychotic treatment with oral risperidone. PANSS-ratings were obtained on day 0, day 1, day 3, day 7 and day 14. RESULTS: Significant effects of treatment were already present on day 1 and continued throughout the study. The PANSS positive subscore and the PANSS total score improved significantly more than the PANSS negative subscore. CONCLUSION: Our results are consistent with the growing number of studies suggesting an early onset of antipsychotic treatment effects. However, non-pharmacological effects of treatment also need to be taken into consideration.

AB - BACKGROUND: The dogma of a delayed onset of antipsychotic treatment effects has been maintained over the past decades. However, recent studies have challenged this concept. We therefore performed an analysis of the onset of antipsychotic treatment effects in a sample of acutely decompensated patients with schizophrenia. METHODS: In this observational study, 48 inpatients with acutely decompensated schizophrenia were offered antipsychotic treatment with oral risperidone. PANSS-ratings were obtained on day 0, day 1, day 3, day 7 and day 14. RESULTS: Significant effects of treatment were already present on day 1 and continued throughout the study. The PANSS positive subscore and the PANSS total score improved significantly more than the PANSS negative subscore. CONCLUSION: Our results are consistent with the growing number of studies suggesting an early onset of antipsychotic treatment effects. However, non-pharmacological effects of treatment also need to be taken into consideration.

U2 - 10.1186/1471-244X-7-4

DO - 10.1186/1471-244X-7-4

M3 - SCORING: Zeitschriftenaufsatz

VL - 7

SP - 4

JO - BMC PSYCHIATRY

JF - BMC PSYCHIATRY

SN - 1471-244X

ER -